UBS AM’s Inari Medical, Inc. Common Stock NARI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,224,052
| Closed | -$62.5M | – | 2718 |
|
|
2024
Q4 | $62.5M | Sell |
1,224,052
-46,939
| -4% | -$2.31M | 0.01% | 619 |
|
|
2024
Q3 | $52.4M | Sell |
1,270,991
-48,011
| -4% | -$2.31M | 0.01% | 669 |
|
|
2024
Q2 | $63.5M | Buy |
1,319,002
+1,247,342
| +1,741% | +$55.3M | 0.02% | 555 |
|
|
2024
Q1 | $3.44M | Buy |
71,660
+8,097
| +13% | +$433K | ﹤0.01% | 1426 |
|
|
2023
Q4 | $4.13M | Buy |
63,563
+2,268
| +4% | +$137K | ﹤0.01% | 1340 |
|
|
2023
Q3 | $4.01M | Buy |
61,295
+8,677
| +16% | +$546K | ﹤0.01% | 1310 |
|
|
2023
Q2 | $3.25M | Hold |
52,618
| – | – | ﹤0.01% | 1415 |
|
|
2023
Q1 | $3.25M | Buy |
52,618
+4,210
| +9% | +$253K | ﹤0.01% | 1415 |
|
|
2022
Q4 | $3.08M | Buy |
48,408
+3,191
| +7% | +$231K | ﹤0.01% | 1347 |
|
|
2022
Q3 | $3.28M | Sell |
45,217
-7,204
| -14% | -$536K | ﹤0.01% | 1346 |
|
|
2022
Q2 | $3.56M | Buy |
52,421
+22,502
| +75% | +$1.62M | ﹤0.01% | 1347 |
|
|
2022
Q1 | $2.71M | Buy |
29,919
+4,223
| +16% | +$346K | ﹤0.01% | 1630 |
|
|
2021
Q4 | $2.35M | Buy |
25,696
+1,239
| +5% | +$106K | ﹤0.01% | 1791 |
|
|
2021
Q3 | $1.98M | Buy |
24,457
+5,228
| +27% | +$439K | ﹤0.01% | 1841 |
|
|
2021
Q2 | $1.79M | Buy |
19,229
+4,470
| +30% | +$433K | ﹤0.01% | 1902 |
|
|
2021
Q1 | $1.58M | Buy |
14,759
+10,959
| +288% | +$1.14M | ﹤0.01% | 1854 |
|
|
2020
Q4 | $332K | Buy |
+3,800
| New | +$268K | ﹤0.01% | 2397 |
|
|
2020
Q3 | – | Sell |
-15,000
| Closed | -$727K | – | 2512 |
|
|
2020
Q2 | $727K | Buy |
+15,000
| New | +$716K | ﹤0.01% | 1938 |
|
Other funds holding NARI
SA
IA
TCWM
PS